ICON Clinical Trials – Overview
ICON Plc. Is a global consulting agency that outsources development and commercialization services to various healthcare-related industries, including pharmaceutical companies, biotechnology companies along with government and public health organizations as well as medical device manufacturers.
The agency is focused on innovating factors that are critical in the healthcare industry to help reduce costs and improve the quality of products and services.
The agency has a team of experts from across the globe with extensive experience in a large variety of therapeutic areas.
Since its inception in 1990, ICON has become one of the world’s most prominent Contract Research Organizations and has received numerous prestigious industry awards for its incredibly high success rate.
Current ICON Clinical Trials
Let’s take a quick look at some of the existing and current clinical trials being conducted by ICON Plc. in 2021:
1 – MY 3853 – 0007
ICON Early Phase Services is organizing a clinical trial for healthy adults between 18 and 45 years old to test the effectiveness of a potential anti-fungal drug.
Participants will need to undergo several tests, including checking medical history, ECGs, vital statistics, drug, alcohol, pregnancy and tobacco testing along with a physical examination as well as provide urine and blood samples during the trial.
You will need to submit a blood sample for testing after an 8-hour fast to determine if you are eligible for participating in this clinical trial. This is a paid trial and participants may be compensated with up to US$ 3,000 to cover time and travel expenses.
For further details on eligibility criteria and application process, feel free to visit the official ICON website at https://study-volunteers.iconplc.com/study-finder/hea-my-3853-0007/.
2 – GL 3507 – 0059
This ICON clinical trial is meant for healthy adult males and females between ages 18 and 55 years and non-smokers.
The aim of this clinical trial is to determine the effectiveness and safety of investigational medicines. This study will focus on an experimental drug developed to treat sickle cell disease and is to be administered orally.
To participate in this study, eligible candidates will be requested to provide their medical history, ECGs, vital signs, drug, alcohol, tobacco tests and also provide samples of their blood, urine and nasopharyngeal fluid.
This is a paid trial where participants will be compensated with up to US$ 15,480 to cover the cost of time and travel expenses. This trial will also provide partial stipend payments too.
To learn more details of eligibility criteria and complete the application process, feel free to call ICON at 210-225-5437 or you can drop an email at their website using https://www.appointmentquest.com/scheduler/2110084437.1 registration link.
3 – AM 5480 – 0009
This ICON clinical trial is aimed at determining the effectiveness and safety of investigational drugs to combat several autoimmune disorders.
The medicine is administered using subcutaneous methods or with an auto-injector and even a pre-filled syringe. This study is looking for healthy adult male and female participants aged between 18 and 45 years old.
The potential participants will have to undergo testing after an 8-hour long fast. Potential participants are also requested to bring any medications they may be currently taking.
This clinical trial does not permit smokers. This is a paid trial and participants will be compensated as much as US$ 10,400 for time and travel expenses.
To find out further details and information on eligibility criteria and application process, you can choose to visit the website and schedule an appointment using https://www.appointmentquest.com/scheduler/2110084437.1 or you can choose to directly call ICON at 210-225-5437.
4 – RE 3877 – 0008
This ICON clinical trial is aimed at ADPKD patients only. This trial is open for participants who are between 18 and 70 years old and are diagnosed with Autosomal Dominant Polycystic Kidney Disease (ADPKD).
This study aims to discover better and more effective treatment methods for combating the symptoms and effects of ADPKD in patients. This trial includes administrating experimental FDA-approved medicines to determine the best and most effective treatment technique for ADPKD.
For more information on this study, feel free to visit the website at https://study-volunteers.iconplc.com/study-finder/re3877-0008/ or call the Recruitment Department at ICON directly using 210-225-5437.
5 – NO 0009 – 0537
This ICON clinical trial is meant for breastfeeding female participants only, aged 18 years and over. The aim of this study is to decide if an FDA-approved drug that is used to treat type-2 diabetes in adults is present in breast milk of lactating women and to determine the amount of the drug which can reach the baby through breastfeeding.
This study will help patients and doctors make a better decision for drugs to treat diabetes in women who are breastfeeding. For more information on eligibility criteria and details feel free to call on 210-225-5437 or you can choose to visit the appointment page at https://www.appointmentquest.com/scheduler/2110084437.1.
These are only the top ICON clinical trials being currently organized by the agency. To find out details on additional clinical trials and trials being planned for the future, feel free to visit the official ICON Plc. website at https://study-volunteers.iconplc.com/study-finder/.